Position in BMY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$329,989
-$17,292 QoQ
Shares Held
5,727
+0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,809
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ranch Capital Advisors Inc. holds $19,506,059 across 8 Drug Manufacturers - General names. BMY ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,434 | $4,427,712 | |
| 2 | AMGN |
Amgen Inc
|
12,108 | $4,384,548 | |
| 3 | ABBV |
AbbVie Inc.
|
16,101 | $4,051,655 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
29,324 | $3,704,794 | |
| 5 | PFE |
Pfizer Inc
|
85,339 | $2,054,963 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
5,727 | $329,989 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,404 | $308,914 | |
| 8 | LLY |
ELI LILLY & Co
|
203 | $243,484 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $329,989 | 5,727 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $347,281 | 5,726 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $308,860 | 5,726 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $267,352 | 5,928 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,650,238 | 35,650 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,082,137 | 34,139 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,830,168 | 32,358 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,614,081 | 31,196 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $215,249 | 5,183 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $280,911 | 5,180 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $265,631 | 5,177 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $301,982 | 5,203 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $339,190 | 5,304 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $367,620 | 5,304 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $383,709 | 5,333 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $379,122 | 5,333 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $410,564 | 5,332 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $389,249 | 5,330 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $332,200 | 5,328 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $315,198 | 5,327 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $355,816 | 5,325 | Principal | Sole | 2021-08-16 | |
| 2021-03-31 | $342,101 | 5,419 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $341,289 | 5,502 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $399,119 | 6,620 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,052,402 | 17,898 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $913,411 | 16,387 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||